Stock screenerAll disclosures →
EDGAR →
PRTA
Conviction 38HealthcareScan · Mon, Aug 10, 2026PRTA$9.12+4.11%
ResistanceSupportVol 14Insider buyVol MA14 630.6K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price9.12
Change+4.11%
Gap+0.34%
Rel volume3.02×
Avg volume606.43K
Avg $ vol5.23M
SMA 208.57
SMA 508.92
SMA 2009.59
Price vs 50+2.28%
Price vs 200-4.89%
MA stackmixed
50/200 cross—
Supertrenddown · 9.45
RSI (14)58
MACD hist0.07
MACD crossbull · 2d
Stoch %K / %D97 / 72
ADX (14)18
+DI / −DI19 / 23
RSI divergence—
MACD divergenceBullish
ATR %+4.96%
ADR %4.77%
52w high11.51
52w low7.54
From 52w high-20.76%
Above 52w low+20.95%
New 52w highNo
SqueezeOn · 3d
Bollinger width9.27%
%B1.19
Donchian pos96.55%
Donchian high9.16
Donchian low8.00
AVWAP (52w high)9.14
vs AVWAP high-0.23%
AVWAP (52w low)9.38
vs AVWAP low-2.80%
OBV trendUp
Chaikin MF (20)0.11
Today vs 20d3.02×
Avg vol (14d)630.6K
Avg vol (20d)606.43K
Avg $ vol (20d)5.23M
Market cap468.19M
RS 3m (vs SPY)-22.43%
RS 6m (vs SPY)-9.20%
RS line new highNo
Trend template2/8
Technical rank48.9
1 week+9.48%
1 month-1.30%
3 months-15.00%
6 months+2.36%
1 year+18.13%
YTD-0.87%
P/E-1.92
P/B1.63
P/S48.35
P/FCF—
EPS-4.53
Div yield—
ROE-85.08%
ROA-80.67%
Debt/Eq—
Current25.05
EV/EBITDA-0.84
Gross margin—
Net margin—
Rev growth-92.84%
EPS growth-99.57%
Price target26.33
Target upside188.71%
Analyst ratingBuy
Institutional97.28%
Ent. value180M
Revenue1.01M
Net income-18.58M
Gross profit—
Free cash flow—
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees67
ListedTue, Dec 18, 2012
Free float42.2M
Float %80.6%
Short interest8.2M
Days to cover16.4d
Short volume68.4%
Squeeze score98 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.32 vs −$0.39
Last surprise+17.9% beat
Setup gradeD
Conviction38 / 100
Pattern quality—
Tech rank48.9 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance10.14
Support7.93
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PRTA
No recent disclosed trades by Congress in PRTA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PRTA · 7 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
SCULLY WILLIAM P 10% owner · Ordinary Shares, par value $0.01 per share · 2026-06-16 | Buy | 20K | $158K | 2026-06-16 | 2026-06-18 |
SCULLY WILLIAM P 10% owner · Ordinary Shares, par value $0.01 per share · 2026-06-04 | Other | — | — | 2026-06-04 | 2026-06-05 |
SCULLY WILLIAM P 10% owner · Ordinary Shares, par value $0.01 per share · 2026-06-04 | Buy | 50K | $465K | 2026-06-04 | 2026-06-05 |
SCULLY WILLIAM P 10% owner · Ordinary Shares, par value $0.01 per share · 2026-06-02 | Other | — | — | 2026-06-02 | 2026-06-03 |
SCULLY WILLIAM P 10% owner · Ordinary Shares, par value $0.01 per share · 2026-06-02 | Buy | 50K | $471K | 2026-06-02 | 2026-06-03 |
SCULLY WILLIAM P 10% owner · Ordinary Shares, par value $0.01 per share · 2026-05-22 | Other | — | — | 2026-05-22 | 2026-05-26 |
SCULLY WILLIAM P 10% owner · Ordinary Shares, par value $0.01 per share · 2026-05-22 | Buy | 100K | $981K | 2026-05-22 | 2026-05-26 |
WELCH DANIEL G Director · Stock Option (Right to Buy) · 2026-05-15 | Grant | 27K | $0 | 2026-05-15 | 2026-05-15 |
Dunn William H. Jr. Director · Stock Option (Right to Buy) · 2026-05-15 | Grant | 27K | $0 | 2026-05-15 | 2026-05-15 |
COLLIER RICHARD T Director · Stock Option (Right to Buy) · 2026-05-15 | Grant | 27K | $0 | 2026-05-15 | 2026-05-15 |
SEC filings
EDGAR filings in PRTA · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.